Effects of Coenzyme Q10 in Progressive Supranuclear Palsy (PSP)

Completed · Not applicable · Has a placebo group

Conditions studied: Progressive Supranuclear Palsy

In brief

The clinical syndrome of PSP responds poorly to all available forms of therapy used in Parkinson's Disease (PD). Currently, no effective treatment exists. Coenzyme Q10 in high doses has been shown to be a beneficial therapy in PD and might possibly be a beneficial therapy for PSP. This study will compare the efficacy, safety and tolerability of Coenzyme Q10 versus placebo in patients with atypical parkinsonian syndrome, progressive supranuclear palsy (PSP).

Key facts

Study ID
NCT00382824
Run by
Lahey Clinic
People needed
61
Starts
2006-09-01
Expected to finish
2015-01-01
Last updated by the study team
2019-08-01

Who can join

Age: 30 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.